<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-2305</identifier>
<setSpec>0300-8932</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Should Treatment with Glycoprotein IIa/IIIb receptor Blocker Be Controlled in Patients Undergoing PCI?</dc:title>
<dc:creator>Heras, Magda</dc:creator>
<dc:language>es</dc:language>
<dc:publisher>Ediciones Doyma, S.L.</dc:publisher>
<dc:description xml:lang="es">No disponible</dc:description>
<dc:source>Rev Esp Cardiol;54(11): 1251-1253, nov. 2001.</dc:source>
<dc:identifier>ibc-2305</dc:identifier>
<dc:title xml:lang="es">¿Se debe controlar el tratamiento con los bloqueadores de la glucoproteína IIb/IIIa en el intervencionismo coronario?</dc:title>
<dc:subject>^d32647</dc:subject>
<dc:subject>^d24519</dc:subject>
<dc:subject>^d22965</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d22214</dc:subject>
<dc:subject>^d920</dc:subject>
<dc:type>article</dc:type>
<dc:date>200111</dc:date>
</metadata>
</record>
</ibecs-document>
